Bio-rad Laboratories Share Price (NYSE: BIO)

$292.78

▲

-3.82

(-1.29%)

Last updated on August 28, 2025 at 1:29 am IST

$₹

Check the interactive Bio-rad Laboratories Stock chart to analyse performance

Bio-rad Laboratories stock performance

as on August 28, 2025 at 1:29 am IST

Today's Low:$291.44
Today's High:$295.94
$292.78
0.46%
Downside
Day's Volatility :1.52%
Upside
1.07%
52 Weeks Low:$211.43
52 Weeks High:$387.99
$292.78
27.79%
Downside
52 Weeks Volatility :45.51%
Upside
24.54%

Bio-rad Laboratories Stock Returns

Period	Bio-rad Laboratories, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	30.3%	4.2%	0.0%
6 Months	11.65%	-8.0%	0.0%
1 Year	-9.79%	-12.0%	0.0%
3 Years	-39.27%	7.7%	-6.9%

Bio-rad Laboratories, Inc. Key Stats

Check Bio-rad Laboratories key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$296.6
Open	$293.47
Today's High	$295.94
Today's Low	$291.44
Market Capitalization	$8.0B
Today's Volume	$191.7K
52 Week High	$387.99
52 Week Low	$211.43
Revenue TTM	$2.6B
EBITDA	$410.3M
Earnings Per Share (EPS)	$10.85
PE Ratio	27.41
Profit Margin	12.5%
Quarterly Earnings Growth YOY	-0.83%
Return On Equity TTM	4.59%

Stock Returns calculator for Bio-rad Laboratories Stock including INR - Dollar returns

The Bio-rad Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Bio-rad Laboratories investment value today

Current value as on today

₹93,744

Returns

₹6,256

(-6.26%)

Returns from Bio-rad Laboratories Stock

₹10,941 (-10.94%)

Dollar Returns*

₹4,685 (+4.68%)

Indian investors sentiment towards Bio-rad Laboratories Stock

64%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Bio-rad Laboratories Stock from India on INDmoney has increased by 64% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Bio-rad Laboratories Stock

Name	Shares Held	Change in Shares	% of Assets
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	28316	1755.59	1.84%

Global Institutional Holdings in Bio-rad Laboratories, Inc.

Name
Holdings %
Name
Holdings %
Arnhold & S. Bleichroeder Advisers, LLC
9.30%
BlackRock Inc
7.47%
Vanguard Group Inc
6.82%
Dimensional Fund Advisors, Inc.
3.69%
Veritas Asset Management LLP
3.19%
Ariel Investments, LLC
3.02%

Analyst Recommendation on Bio-rad Laboratories Stock

Rating

Trend

Buy

60%Buy

40%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Bio-rad Laboratories(by analysts ranked 0 to 5 stars)

Bio-rad Laboratories Share Price Target

What analysts predicted

Upside of 11.52%

Target:

$326.50

Current:

$292.78

Bio-rad Laboratories share price target is $326.50, a slight Upside of 11.52% compared to current price of $292.78 as per analysts' prediction.

Bio-rad Laboratories Stock Insights

Price Movement
In the last 1 month, BIO stock has moved up by 17.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 585.4M → 651.6M (in $), with an average increase of 10.2% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -715.8M → 317.8M (in $), with an average increase of 649.2% per quarter
BIO vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 33.8% return, outperforming this stock by 43.6%
BIO vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 162.6% return, outperforming this stock by 202.7%
Price to Sales
ForBIO every $1 of sales, investors are willing to pay $3.2, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Bio-rad Laboratories, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$2.3B	↑ 0.94%
Net Income	$1.8B	↑ 387.17%
Net Profit Margin	76.08%	↑ 60.32%

	FY20	Y/Y Change
Revenue	$2.5B	↑ 10.12%
Net Income	$3.8B	↑ 116.88%
Net Profit Margin	149.83%	↑ 73.75%

	FY21	Y/Y Change
Revenue	$2.9B	↑ 14.81%
Net Income	$4.3B	↑ 11.54%
Net Profit Margin	145.57%	↓ 4.26%

	FY22	Y/Y Change
Revenue	$2.8B	↓ 4.12%
Net Income	$-3.6B	↓ 185.27%
Net Profit Margin	-129.45%	↓ 275.02%

	FY23	Y/Y Change
Revenue	$2.7B	↓ 4.67%
Net Income	$-637.3M	↓ 82.43%
Net Profit Margin	-23.86%	↑ 105.59%

	FY24	Y/Y Change
Revenue	$2.6B	↓ 3.92%
Net Income	$-1.8B	↑ 189.37%
Net Profit Margin	-71.86%	↓ 48.0%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$610.8M	↓ 10.33%
Net Income	$383.9M	↑ 9.78%
Net Profit Margin	62.85%	↑ 11.51%

	Q2 FY24	Q/Q Change
Revenue	$638.5M	↑ 4.53%
Net Income	$-2.2B	↓ 664.05%
Net Profit Margin	-339.16%	↓ 402.01%

	Q3 FY24	Q/Q Change
Revenue	$649.7M	↑ 1.76%
Net Income	$653.2M	↓ 130.16%
Net Profit Margin	100.53%	↑ 439.69%

	Q4 FY24	Q/Q Change
Revenue	$667.5M	↑ 2.73%
Net Income	$-715.8M	↓ 209.59%
Net Profit Margin	-107.24%	↓ 207.77%

	Q1 FY25	Q/Q Change
Revenue	$585.4M	↓ 12.3%
Net Income	$64.0M	↓ 108.94%
Net Profit Margin	10.93%	↑ 118.17%

	Q2 FY25	Q/Q Change
Revenue	$651.6M	↑ 11.31%
Net Income	$317.8M	↑ 396.56%
Net Profit Margin	48.77%	↑ 37.84%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$1.3B	↑ 2.67%

	FY20	Y/Y Change
Profit	$1.4B	↑ 14.39%

	FY21	Y/Y Change
Profit	$1.6B	↑ 13.92%

	FY22	Y/Y Change
Profit	$1.6B	↓ 4.32%

	FY23	Y/Y Change
Profit	$1.4B	↓ 8.96%

	FY24	Y/Y Change
Profit	$1.4B	↓ 3.37%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$326.5M	↓ 10.78%

	Q2 FY24	Q/Q Change
Profit	$355.1M	↑ 8.78%

	Q3 FY24	Q/Q Change
Profit	$355.9M	↑ 0.22%

	Q4 FY24	Q/Q Change
Profit	$341.9M	↓ 3.93%

	Q1 FY25	Q/Q Change
Profit	$306.0M	↓ 10.5%

	Q2 FY25	Q/Q Change
Profit	$345.4M	↑ 12.88%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$457.9M	↑ 60.39%
Investing Cash Flow	$-208.9M	↑ 11.72%
Financing Cash Flow	$-22.8M	↓ 53.25%

	FY20	Y/Y Change
Operating Cash Flow	$585.0M	↑ 27.75%
Investing Cash Flow	$-69.9M	↓ 66.54%
Financing Cash Flow	$-523.0M	↑ 2198.27%

	FY21	Y/Y Change
Operating Cash Flow	$656.5M	↑ 12.23%
Investing Cash Flow	$-784.4M	↑ 1022.33%
Financing Cash Flow	$-55.4M	↓ 89.4%

	FY22	Y/Y Change
Operating Cash Flow	$194.4M	↓ 70.38%
Investing Cash Flow	$-1.2B	↑ 53.94%
Financing Cash Flow	$973.6M	↓ 1856.44%

	FY23	Y/Y Change
Operating Cash Flow	$374.9M	↑ 92.83%
Investing Cash Flow	$20.2M	↓ 101.67%
Financing Cash Flow	$-425.6M	↓ 143.72%

	FY24	Y/Y Change
Operating Cash Flow	$455.2M	↑ 21.41%
Investing Cash Flow	$-160.2M	↓ 892.76%
Financing Cash Flow	$-218.8M	↓ 48.6%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$69.8M	↓ 13.89%
Investing Cash Flow	$-43.1M	↓ 159.69%
Financing Cash Flow	$21.0K	↓ 100.01%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$97.6M	↑ 39.91%
Investing Cash Flow	$-30.9M	↓ 28.23%
Financing Cash Flow	$-96.6M	↓ 460038.1%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$163.6M	↑ 67.55%
Investing Cash Flow	$-55.6M	↑ 79.89%
Financing Cash Flow	$-96.0M	↓ 0.62%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$124.2M	↓ 24.12%
Investing Cash Flow	$-30.5M	↓ 45.1%
Financing Cash Flow	$-26.2M	↓ 72.65%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$129.9M	↑ 4.63%
Investing Cash Flow	$2.9M	↓ 109.49%
Financing Cash Flow	$-97.7M	↑ 272.22%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$116.5M	↓ 10.32%
Investing Cash Flow	$-115.4M	↓ 4079.31%
Financing Cash Flow	$-136.3M	↑ 39.51%

Bio-rad Laboratories Technicals Summary

Sell

Neutral

Buy

Bio-rad Laboratories is currently in a neutral trading position according to technical analysis indicators.

Bio-rad Laboratories, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bio-rad Laboratories, Inc.	17.11%	11.65%	-9.79%	-39.27%	-41.69%
Medtronic Plc	0.22%	1.58%	4.35%	3.67%	-14.23%
Edwards Lifesciences Corp.	3.54%	13.82%	18.38%	-10.06%	-5.32%
Boston Scientific Corp.	0.54%	5.57%	33.82%	163.46%	159.41%
Stryker Corporation	-1.53%	1.45%	10.78%	90.79%	99.11%
Abbott Laboratories	2.81%	-3.14%	16.57%	29.23%	20.22%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bio-rad Laboratories, Inc.	27.41	27.41	1.19	9.65	0.05	0.02	NA	263.42
Medtronic Plc	25.61	25.61	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	34.0	34.0	4.83	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.57	62.57	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.64	51.64	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.55	16.55	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bio-rad Laboratories, Inc.	Buy	$8.0B	-41.69%	27.41	12.5%
Medtronic Plc	Buy	$118.8B	-14.23%	25.61	13.63%
Edwards Lifesciences Corp.	Buy	$47.7B	-5.32%	34.0	72.96%
Boston Scientific Corp.	Buy	$155.7B	159.41%	62.57	13.55%
Stryker Corporation	Buy	$149.4B	99.11%	51.64	12.25%
Abbott Laboratories	Buy	$229.5B	20.22%	16.55	32.43%

About Bio-rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Organization	Bio-rad Laboratories
Employees	7700
CEO	Mr. Norman D. Schwartz
Industry	Health Technology

Key Management of Bio-rad Laboratories, Inc.

Name	Title
Mr. Norman D. Schwartz	Chairman & CEO
Mr. Jonathan P. DiVincenzo	President & COO
Mr. Roop K. Lakkaraju CPA	Executive VP & CFO
Mr. Michael Crowley	Executive Vice President of Global Commercial Operations
Ms. Anette Engelhardt	Executive VP & President of the Clinical Diagnostics Group
Mr. Yong Chung	Vice President of Investor Relations
Matthew Werner	Senior Vice President and Chief Compliance & Privacy Officer
Courtney C. Enloe	Executive VP, General Counsel & Secretary
Ms. Colleen Corey	Executive Vice President of Global Human Resources
Lee Boyd	Senior Vice President of Global Commercial Operations - Asia Pacific

Important FAQs about investing in BIO Stock from India :

What is Bio-rad Laboratories share price today?

Bio-rad Laboratories share price today is $292.78 as on August 28, 2025 at 1:29 am IST at the close of the market. Bio-rad Laboratories share today touched a day high of $295.94 and a low of $291.44.

What is the 52 week high and 52 week low for Bio-rad Laboratories share?

Bio-rad Laboratories share touched a 52 week high of $387.99 and a 52 week low of $211.43. Bio-rad Laboratories stock price today i.e. August 28, 2025 at 1:29 am IST is closed at $292.78, lower by 24.54% versus the 52 week high.

How to invest in Bio-rad Laboratories Stock (BIO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bio-rad Laboratories on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bio-rad Laboratories Shares that will get you 0.0051 shares as per Bio-rad Laboratories share price of $292.78 per share as on August 28, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bio-rad Laboratories Stock (BIO) from India?

Indian investors can start investing in Bio-rad Laboratories (BIO) shares with as little as ₹87.86 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Bio-rad Laboratories stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Bio-rad Laboratories share’s latest price of $292.78 as on August 28, 2025 at 1:29 am IST, you will get 0.0342 shares of Bio-rad Laboratories. Learn more about fractional shares .

What are the returns that Bio-rad Laboratories has given to Indian investors in the last 5 years?

Bio-rad Laboratories stock has given -41.69% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?